Page last updated: 2024-10-24

cefuroxime and Carcinoma, Bronchial

cefuroxime has been researched along with Carcinoma, Bronchial in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Cefuroxime was assayed using HPLC on ground tissues, with a correction for contamination by blood."1.28[Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection]. ( Azorin, J; Brion, N; Chiche, D; Farinotti, R; Le Gros, V; Parrot, AM; Regnard, JF, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Gros, V1
Farinotti, R1
Brion, N1
Regnard, JF1
Azorin, J1
Parrot, AM1
Chiche, D1

Other Studies

1 other study available for cefuroxime and Carcinoma, Bronchial

ArticleYear
[Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
    Pathologie-biologie, 1992, Volume: 40, Issue:5

    Topics: Adult; Aged; Bronchi; Carcinoma, Bronchogenic; Cefuroxime; Female; Humans; Injections, Intramuscular

1992